Woofun AI notes that Cathie Wood identifies multiomics as a pivotal AI application capable of restructuring the medical sector. ARK Invest research indicates that integrating multi-omics with artificial intelligence facilitates early disease detection prior to symptom onset while significantly reducing new drug development timelines and expenses. This convergence is expected to accelerate innovative therapy delivery, fundamentally enhancing healthcare system efficiency. Wood argues this evolution will transition the medical model from traditional "sickcare" to genuine "healthcare", moving from passive treatment to proactive prevention.